| pubmed-article:21497551 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0681916 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0750572 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0449820 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0680844 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C1519941 | lld:lifeskim |
| pubmed-article:21497551 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
| pubmed-article:21497551 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21497551 | pubmed:dateCreated | 2011-5-31 | lld:pubmed |
| pubmed-article:21497551 | pubmed:abstractText | Therapy for chronic hepatitis B reduces the risk of progressing to hepatocellular carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This study aimed to develop and validate a simple scoring system to predict HCC risk in patients with chronic hepatitis B. | lld:pubmed |
| pubmed-article:21497551 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21497551 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21497551 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21497551 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21497551 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21497551 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21497551 | pubmed:issn | 1474-5488 | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:ChenPei-JerPJ | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:ChenChien-Jen... | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:ChanHenry... | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:YuenMan-FungM... | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:HanKwang-Hyub... | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:YangHwai-IHI | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:WongVincent... | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:AhnSang-HoonS... | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:KimDo-YoungDY | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:SetoWai-KayWK | lld:pubmed |
| pubmed-article:21497551 | pubmed:author | pubmed-author:REACH-B... | lld:pubmed |
| pubmed-article:21497551 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21497551 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21497551 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:21497551 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21497551 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21497551 | pubmed:pagination | 568-74 | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:meshHeading | pubmed-meshheading:21497551... | lld:pubmed |
| pubmed-article:21497551 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21497551 | pubmed:articleTitle | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. | lld:pubmed |
| pubmed-article:21497551 | pubmed:affiliation | Genomics Research Centre, Academia Sinica, Taipei, Taiwan. | lld:pubmed |
| pubmed-article:21497551 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21497551 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21497551 | lld:pubmed |
